Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vinyl Chloride SCHEMBL7901044 | 0.82 | CYP3A4 (0.67) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Methylene Chloride SCHEMBL958149 | 0.82 | CYP3A4 (0.75) | CYP3A4TDP1ESR1ESR2KDM4E | |
| SCHEMBL1652820 | 0.81 | TDP1 (0.57) | CYP3A4TDP1ESR1ESR2KDM4E | |
| SCHEMBL28392639 | 0.81 | CYP3A4 (0.57) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Allylamine SCHEMBL29191439 | 0.81 | CYP3A4 (0.57) | CYP3A4TDP1ESR1ESR2KDM4E | |
| SCHEMBL10739432 | 0.81 | TDP1 (0.57) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Vinyl Chloride SCHEMBL7604262 | 0.80 | CYP3A4 (0.63) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Bromide SCHEMBL28986930 | 0.79 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Bromide SCHEMBL28395471 | 0.79 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2KDM4E | |
| Iodide SCHEMBL28394575 | 0.79 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109593250-A | A kind of pearl cotton and preparation method thereof for low frequency electromagnetic physiotherapy cushion | 广州三得医疗科技有限公司 | 2019-04-09 | — | — | CN | claimed |
| CN-117624455-A | Emulsion type acid thickener and preparation method thereof | 东营施普瑞石油工程技术有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-109593250-A | A kind of pearl cotton and preparation method thereof for low frequency electromagnetic physiotherapy cushion | 广州三得医疗科技有限公司 | 2019-04-09 | — | — | CN | disclosed |
| CN-108837845-A | A kind of basic catalyst and preparation method and application of anti-hydrogen chloride | 浙江工业大学 | 2018-11-20 | — | — | CN | disclosed |
| US-20070142657-A1 | Process for the preparation of aliphatic primary alcohols and intermediates in such process | DSM IP ASSETS B.V. (NL) | 2007-06-21 | — | — | US | disclosed |
| EP-1685089-A1 | PROCESS FOR THE PREPARATION OF ALIPHATIC PRIMARY ALCOHOLS AND INTERMEDIATES IN SUCH PROCESS | DSM IP Assets B.V. (NL) | 2006-08-02 | — | — | EP | disclosed |
| WO-2006042835-A1 | PROCESS FOR THE PREPARATION OF ALIPHATIC PRIMARY ALCOHOLS AND RELATED INTERMEDIATES IN SUCH PROCESS | DSM IP ASSETS B.V. (NL) | 2006-04-27 | — | — | WO | disclosed |
| WO-2005047221-A1 | PROCESS FOR THE PREPARATION OF ALIPHATIC PRIMARY ALCOHOLS AND INTERMEDIATES IN SUCH PROCESS | DSM IP ASSETS B.V. (NL) | 2005-05-26 | — | — | WO | disclosed |
| US-5233106-A | PROCESS FOR THE HYDROGENATION OF CHLOROMETHANES | WACKER-CHEMIE GMBH (DE) | 1993-08-03 | — | — | US | disclosed |
| US-3997705-A | Method of coagulating a fluoro-elastomer from an aqueous dispersion thereof | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142657-A1 | Process for the preparation of aliphatic primary alcohols and intermediates in such process | CYP2E1, MSMO1, ADH1C | CYP3A4 225/4885TDP1 4711/4885ESR1 392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.